Mammalian target of rapamycin (mTOR) signaling serves as a central regulator of cell growth, proliferation, and survival by interacting with various proteins. To date, few studies implicated mTOR in placenta. Human placenta in gestational diabetes mellitus (GDM) shows several alterations including villous immaturity, impaired placental function, and overgrowth. Hence, we aimed to investigate the expression of mTOR, phospho-mTOR (p-mTOR), and the 2 phosphorylated downstream targets of mTOR, ribosomal protein S6 kinase 1 (p-p70S6K), and eukaryotic initiation factor 4E-binding protein 1 (p-4EBP1) in normal term and gestational diabetic human placentas. Immunohistochemistry and Western blot were performed with antibodies against mTOR, p-mTOR, p-p70S6K, and p-4EBP1 (Thr37/46) in normal and diabetic placentas (n = 6 each) and quantified by ImageJ. All mTOR pathway components that we studied were immunolocalized in both normal and diabetic placenta groups. Syncytiotrophoblast and the vascular wall in villi displayed cytoplasmic mTOR and p-mTOR (S2448) immunoreactivities in all placenta samples. However, increased expression of p70S6K in syncytiotrophoblast and p-4EBP1 (Thr37/46) in villous stromal cells was observed in gestational diabetic placentas. Western blot analysis also confirmed the statistically significant increase in p-p70S6K (T389) expression in diabetic placentas. The altered expression of downstream components of mTOR signaling in gestational diabetic placentas suggests an involvement of mTOR activity in the placental pathology of GDM. However, whether increased nutrient transport via this pathway will stimulate fetal and placental overgrowth is still unknown. Although this is a descriptive study, further studies with a functional analysis to highlight the molecular mechanisms underlying this placental pathology are proposed.
VambergueAFajardyI. Consequences of gestational and pregestational diabetes on placental function and birth weight. World J Diabetes. 2011;2(11):196–203.
2.
SingerDBWidnessJALiuCTEllisRA. Placentas in pregnancies complicated by maternal diabetes. Surv Synth Pathol Res. 1984;3(4):333–341.
3.
DiamantYZ. The human placenta in diabetes mellitus. Isr J Med Sci. 1991;27(8-9):493–497.
4.
GausterMDesoyeGTotschMHidenU. The placenta and gestational diabetes mellitus. Curr Diab Rep. 2012;12(1):16–23.
5.
CatalanoPMKirwanJPHaugel-de MouzonSKingJ. Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus. J Nutr. 2003;133(5 suppl 2):1674S–1683 S.
6.
McFarlandMBTrylovichCGLangerO. Anthropometric differences in macrosomic infants of diabetic and nondiabetic mothers. J Matern Fetal Med. 1998;7(6):292–295.
7.
ThomasGHallMN. TOR signalling and control of cell growth. Curr Opin Cell Biol. 1997;9(6):782–787.
8.
WullschlegerSLoewithRHallMN. TOR signaling in growth and metabolism. Cell. 2006;124(3):471–484.
ArroyoJABrownLDGalanHL. Placental mammalian target of rapamycin and related signaling pathways in an ovine model of intrauterine growth restriction. Am J Obstet Gynecol. 2009;201(6):616 e611–617.
11.
GaccioliFWhiteVCapobiancoEPowellTLJawerbaumAJanssonT. Maternal overweight induced by a diet with high content of saturated fat activates placental mTOR and eIF2alpha signaling and increases fetal growth in rats. Biol Reprod. 2013;89(4):96.
12.
GangloffYGMuellerMDannSG. Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development. Mol Cell Biol. 2004;24(21):9508–9516.
13.
MurakamiMIchisakaTMaedaM. mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells. Mol Cell Biol. 2004;24(15):6710–6718.
14.
BuschSRenaudSJSchleussnerEGrahamCHMarkertUR. mTOR mediates human trophoblast invasion through regulation of matrix-remodeling enzymes and is associated with serine phosphorylation of STAT3. Exp Cell Res. 2009;315(10):1724–1733.
15.
KnuthALiuLNielsenHMerrilDTorryDSArroyoJA. Placenta Growth Factor Induces Invasion and Activates p70 during Rapamycin Treatment in Trophoblast Cells. Am J Reprod Immunol. 2015;73(4):330–340.
16.
OzmenAUnekGKipmen-KorgunDCetinkayaBAvcilZKorgunET. Glucocorticoid exposure altered angiogenic factor expression via Akt/mTOR pathway in rat placenta. Ann Anat. 2015;198:34–40.
17.
WenHYAbbasiSKellemsREXiaY. mTOR: a placental growth signaling sensor. Placenta. 2005;26(suppl A):S63–S69.
18.
JanssonTAyeILGoberdhanDC. The emerging role of mTORC1 signaling in placental nutrient-sensing. Placenta. 2012;33(suppl 2):e23–e29.
19.
RoosSJanssonNPalmbergISaljoKPowellTLJanssonT. Mammalian target of rapamycin in the human placenta regulates leucine transport and is down-regulated in restricted fetal growth. J Physiol. 2007;582(pt 1):449–459.
20.
YungHWCalabreseSHynxD. Evidence of placental translation inhibition and endoplasmic reticulum stress in the etiology of human intrauterine growth restriction. Am J Pathol. 2008;173(2):451–462.
21.
TariccoERadaelliTNobile de SantisMSCetinI. Foetal and placental weights in relation to maternal characteristics in gestational diabetes. Placenta. 2003;24(4):343–347.
22.
MetzgerBEGabbeSGPerssonB. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676–682.
YungHWColleoniFAtkinsonD. Influence of speed of sample processing on placental energetics and signalling pathways: implications for tissue collection. Placenta. 2014;35(2):103–108.
25.
SatiLSeval-CelikYUnekGKorgunETDemirR. The presence of kinesin superfamily motor proteins KIFC1 and KIF17 in normal and pathological human placenta. Placenta. 2009;30(10):848–854.
26.
SatiLSeval-CelikYDemirR. Lung surfactant proteins in the early human placenta. Histochem Cell Biol. 2010;133(1):85–93.
27.
JensenEC. Quantitative analysis of histological staining and fluorescence using ImageJ. Anat Rec (Hoboken). 2013;296(3):378–381.
28.
JahanSAhmedCMZinnatR. Influence of maternal diabetes on serum leptinemic and insulinemic status of the offspring: a case study of selected patients in a tertiary care hospital in Bangladesh. Diabetes Metab Syndr. 2011;5(1):33–37.
29.
JanssonNGreenwoodSLJohanssonBRPowellTLJanssonT. Leptin stimulates the activity of the system A amino acid transporter in human placental villous fragments. J Clin Endocrinol Metab. 2003;88(3):1205–1211.
30.
VolarevicSThomasG. Role of S6 phosphorylation and S6 kinase in cell growth. Prog Nucleic Acid Res Mol Biol. 2001;65:101–127.
31.
RousseauDGingrasACPauseASonenbergN. The eIF4E-binding proteins 1 and 2 are negative regulators of cell growth. Oncogene. 1996;13(11):2415–2420.
32.
MparmpakasDZachariadesEFosterH. Expression of mTOR and downstream signalling components in the JEG-3 and BeWo human placental choriocarcinoma cell lines. Int J Mol Med. 2010;25(1):65–69.
33.
RosarioFJKanaiYPowellTLJanssonT. Mammalian target of rapamycin signalling modulates amino acid uptake by regulating transporter cell surface abundance in primary human trophoblast cells. J Physiol. 2013;591(pt 3):609–625.
34.
RoosSKanaiYPrasadPDPowellTLJanssonT. Regulation of placental amino acid transporter activity by mammalian target of rapamycin. Am J Physiol Cell Physiol. 2009;296(1):C142–C150.
JanssonNRosarioFJGaccioliF. Activation of placental mTOR signaling and amino acid transporters in obese women giving birth to large babies. J Clin Endocrinol Metab. 2013;98(1):105–113.
37.
LiuYHidayatSSuWHDengXYuDHYuBZ. Expression and activity of mTOR and its substrates in different cell cycle phases and in oral squamous cell carcinomas of different malignant grade. Cell Biochem Funct. 2007;25(1):45–53.
38.
MparmpakasDZachariadesEGoumenouAGidronYKarterisE. Placental DEPTOR as a stress sensor during pregnancy. Clin Sci (Lond). 2012;122(7):349–359.
39.
AikoYAskewDJAramakiS. Differential levels of amino acid transporters System L and ASCT2, and the mTOR protein in placenta of preeclampsia and IUGR. BMC Pregnancy Childbirth. 2014;14:181.
40.
Perez-PerezAMaymoJLGambinoYP. Activated translation signaling in placenta from pregnant women with gestational diabetes mellitus: possible role of leptin. Horm Metab Res. 2013;45(6):436–442.
41.
Perez-PerezAGambinoYMaymoJ. MAPK and PI3 K activities are required for leptin stimulation of protein synthesis in human trophoblastic cells. Biochem Biophys Res Commun. 2010;396(4):956–960.
42.
Perez-PerezAMaymoJGambinoY. Leptin stimulates protein synthesis-activating translation machinery in human trophoblastic cells. Biol Reprod. 2009;81(5):826–832.
43.
BifulcoGDi CarloCCarusoM. Glucose regulates insulin mitogenic effect by modulating SHP-2 activation and localization in JAr cells. J Biol Chem. 2002;277(27):24306–24314.
44.
ChungJGrammerTCLemonKPKazlauskasABlenisJ. PDGF- and insulin-dependent pp70S6 k activation mediated by phosphatidylinositol-3-OH kinase. Nature. 1994;370(6484):71–75.
45.
DiggleTAMouleSKAvisonMB. Both rapamycin-sensitive and -insensitive pathways are involved in the phosphorylation of the initiation factor-4E-binding protein (4E-BP1) in response to insulin in rat epididymal fat-cells. Biochem J. 1996;316 (pt 2):447–453.
46.
SmithJAPoteet-SmithCEMalarkeyKSturgillTW. Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo. J Biol Chem. 1999;274(5):2893–2898.
